098470565	098470565	CD	B-NP	O
|	|	NN	I-NP	O
TH	TH	NN	I-NP	O
|	|	NN	I-NP	O
86372968	86372968	CD	I-NP	O
|	|	NN	I-NP	O
|	|	NN	I-NP	O
2684489	2684489	CD	B-NP	O
|	|	CC	I-NP	O
3/20/2007	3/20/2007	CD	I-NP	O
12	12	CD	I-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
AM	AM	VBP	B-VP	O
|	|	JJ	B-NP	B-protein
Cardiac	Cardiac	NNP	I-NP	I-protein
Transplant	Transplant	NNP	I-NP	I-protein
vasculopathy	vasculopathy	NN	I-NP	I-protein
|	|	NN	I-NP	I-protein
|	|	NNP	I-NP	O
DIS	DIS	NNP	I-NP	O
|	|	NNP	I-NP	O
Admission	Admission	NNP	I-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
10/28/2007	10/28/2007	CD	B-NP	O
Report	Report	NNP	I-NP	O
Status	Status	NNP	I-NP	O
:	:	:	O	O
Discharge	Discharge	NNP	B-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
2/13/2007	2/13/2007	CD	B-NP	O
******	******	SYM	I-NP	O
FINAL	FINAL	NN	I-NP	O
DISCHARGE	DISCHARGE	NN	I-NP	O
ORDERS	ORDERS	NNS	I-NP	O
******	******	SYM	O	O
GEITGEY	GEITGEY	NNP	B-NP	O
,	,	,	O	O
RICO	RICO	NNP	B-NP	O
801-23-18-1	801-23-18-1	CD	I-NP	O
Villeral	Villeral	NNP	I-NP	O
Ivan	Ivan	NNP	I-NP	O
Gardcouvillehdola	Gardcouvillehdola	NNP	I-NP	O
,	,	,	O	O
Minnesota	Minnesota	NNP	B-NP	O
Service	Service	NNP	I-NP	O
:	:	:	O	O
CAR	CAR	NN	B-NP	O
DISCHARGE	DISCHARGE	NN	I-NP	O
PATIENT	PATIENT	NN	I-NP	O
ON	ON	NN	I-NP	O
:	:	:	O	O
3/10/07	3/10/07	CD	B-NP	O
AT	AT	NN	I-NP	O
05	05	CD	I-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
PM	PM	NNP	I-NP	O
CONTINGENT	CONTINGENT	NNP	I-NP	O
UPON	UPON	NNP	I-NP	O
Not	Not	NNP	I-NP	O
Applicable	Applicable	NNP	I-NP	O
WILL	WILL	NNP	I-NP	O
D/C	D/C	NNP	I-NP	O
ORDER	ORDER	NNP	I-NP	O
BE	BE	NNP	I-NP	O
USED	USED	NNP	I-NP	O
AS	AS	NNP	I-NP	O
THE	THE	NNP	I-NP	O
D/C	D/C	NNP	I-NP	O
SUMMARY	SUMMARY	NNP	I-NP	O
:	:	:	O	O
YES	YES	NNP	B-NP	O
Attending	Attending	NNP	I-NP	O
:	:	:	O	O
BURGUN	BURGUN	NNP	B-NP	O
,	,	,	O	O
DAVIS	DAVIS	NNP	B-NP	O
ELISEO	ELISEO	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
CODE	CODE	NNP	I-NP	O
STATUS	STATUS	NNP	I-NP	O
:	:	:	O	O
Full	Full	JJ	B-NP	O
code	code	NN	I-NP	O
DISPOSITION	DISPOSITION	NN	I-NP	O
:	:	:	O	O
Home	Home	NNP	B-NP	O
MEDICATIONS	MEDICATIONS	NNP	I-NP	O
ON	ON	NNP	I-NP	O
ADMISSION	ADMISSION	NNP	I-NP	O
:	:	:	O	O
1	1	CD	B-NP	O
.	.	.	O	O

ENALAPRIL	ENALAPRIL	NN	B-NP	O
MALEATE	MALEATE	NN	I-NP	O
10	10	CD	I-NP	O
MG	MG	NN	I-NP	O
PO	PO	NN	I-NP	O
QD	QD	NN	I-NP	O
2	2	CD	I-NP	O
.	.	.	O	O

FUROSEMIDE	FUROSEMIDE	RB	B-NP	O
40	40	CD	I-NP	O
MG	MG	NN	I-NP	O
PO	PO	NN	I-NP	O
QD	QD	NN	I-NP	O
3	3	CD	I-NP	O
.	.	.	O	O

PREDNISONE	PREDNISONE	NN	B-NP	O
5	5	CD	I-NP	O
MG	MG	NN	I-NP	O
PO	PO	NN	I-NP	O
QAM	QAM	NN	I-NP	O
4	4	CD	I-NP	O
.	.	.	O	O

DILTIAZEM	DILTIAZEM	NN	B-NP	O
EXTENDED	EXTENDED	VBD	B-VP	O
RELEASE	RELEASE	NN	B-NP	B-protein
-LRB-	-LRB-	HYPH	B-NP	O
24	24	CD	I-NP	O
HR	HR	NN	I-NP	O
CAP	CAP	NN	I-NP	O
-RRB-	-RRB-	HYPH	B-NP	O
360	360	CD	I-NP	O
MG	MG	NN	I-NP	O
PO	PO	NN	I-NP	O
QD	QD	NN	I-NP	O
5	5	CD	I-NP	O
.	.	.	O	O

CLOPIDOGREL	CLOPIDOGREL	NN	B-NP	O
75	75	CD	I-NP	O
MG	MG	NN	I-NP	O
PO	PO	NN	I-NP	O
QD	QD	NN	I-NP	O
6	6	CD	I-NP	O
.	.	.	O	O

KDUR	KDUR	NN	B-NP	O
20	20	CD	I-NP	O
MEQ	MEQ	NN	I-NP	O
PO	PO	NN	I-NP	O
QD	QD	NN	I-NP	O
7	7	CD	I-NP	O
.	.	.	O	O

RANITIDINE	RANITIDINE	NN	B-NP	B-protein
HCL	HCL	NN	I-NP	I-protein
150	150	CD	I-NP	I-protein
MG	MG	NN	I-NP	I-protein
PO	PO	NN	I-NP	I-protein
QD	QD	NN	I-NP	I-protein
8	8	CD	I-NP	I-protein
.	.	.	O	O

ATORVASTATIN	ATORVASTATIN	NNP	B-NP	O
PO	PO	NNP	I-NP	O
QD	QD	NNP	I-NP	B-protein
9	9	CD	I-NP	I-protein
.	.	.	O	O

CYCLOSPORINE	CYCLOSPORINE	NN	B-NP	O
MICRO	MICRO	NN	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
NEORAL	NEORAL	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
25	25	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
BID	BID	NNP	I-NP	O
10	10	CD	I-NP	O
.	.	.	O	O

SIROLIMUS	SIROLIMUS	NN	B-NP	B-protein
1	1	CD	I-NP	I-protein
MG	MG	NN	I-NP	I-protein
PO	PO	NN	I-NP	I-protein
QD	QD	NNP	I-NP	O
MEDICATIONS	MEDICATIONS	NNP	I-NP	O
ON	ON	NNP	I-NP	O
DISCHARGE	DISCHARGE	NNP	I-NP	O
:	:	:	O	O
LIPITOR	LIPITOR	NN	B-NP	O
-LRB-	-LRB-	NN	I-NP	O
ATORVASTATIN	ATORVASTATIN	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
80	80	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
DAILY	DAILY	NNP	I-NP	O
Override	Override	NNP	I-NP	O
Notice	Notice	NNP	I-NP	O
:	:	:	O	O
Override	Override	NNP	B-NP	O
added	add	VBD	B-VP	O
on	on	IN	B-PP	O
7/25/07	7/25/07	CD	B-NP	O
by	by	IN	B-PP	O
BRANSFIELD	BRANSFIELD	NNP	B-NP	O
,	,	,	O	O
JIMMIE	JIMMIE	NNP	B-NP	O
P	P	NNP	I-NP	O
N.	N.	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
on	on	IN	B-PP	O
order	order	NN	B-NP	O
for	for	IN	B-PP	O
CYCLOSPORINE	CYCLOSPORINE	NN	B-NP	O
-LRB-	-LRB-	HYPH	B-NP	O
SANDIMMUNE	SANDIMMUNE	NN	I-NP	B-protein
-RRB-	-RRB-	NN	I-NP	I-protein
PO	PO	NN	I-NP	I-protein
-LRB-	-LRB-	NN	I-NP	I-protein
ref	ref	NN	I-NP	I-protein
#	#	#	B-NP	I-protein
632494871	632494871	CD	I-NP	I-protein
-RRB-	-RRB-	NNP	I-NP	I-protein
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
ATORVASTATIN	ATORVASTATIN	NNP	B-NP	O
CALCIUM	CALCIUM	NNP	I-NP	O
&	&	CC	I-NP	O
CYCLOSPORINE	CYCLOSPORINE	NNP	I-NP	O
Reason	Reason	NNP	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
followed	follow	VBN	B-NP	O
PLAVIX	PLAVIX	NN	I-NP	B-DNA
-LRB-	-LRB-	NN	I-NP	I-DNA
CLOPIDOGREL	CLOPIDOGREL	NN	I-NP	I-DNA
-RRB-	-RRB-	HYPH	O	I-DNA
75	75	CD	B-NP	I-DNA
MG	MG	NNP	I-NP	I-DNA
PO	PO	NNP	I-NP	I-DNA
DAILY	DAILY	NNP	I-NP	I-DNA
CYCLOSPORINE	CYCLOSPORINE	NNP	I-NP	I-DNA
-LRB-	-LRB-	NNP	I-NP	I-DNA
SANDIMMUNE	SANDIMMUNE	NNP	I-NP	I-DNA
-RRB-	-RRB-	NNP	I-NP	I-DNA
25	25	CD	I-NP	I-DNA
MG	MG	NNP	I-NP	I-DNA
PO	PO	NNP	I-NP	I-DNA
BID	BID	NNP	I-NP	I-DNA
Food/Drug	Food/Drug	NNP	I-NP	I-DNA
Interaction	Interaction	NNP	I-NP	I-DNA
Instruction	Instruction	NNP	I-NP	I-DNA
Avoid	Avoid	NNP	I-NP	I-DNA
grapefruit	grapefruit	NN	I-NP	I-DNA
unless	unless	IN	B-SBAR	I-DNA
MD	MD	NN	B-NP	I-DNA
instructs	instruct	NNS	I-NP	I-DNA
otherwise	otherwise	RB	B-ADVP	O
.	.	.	O	O

Give	Give	VB	B-VP	O
with	with	IN	B-PP	O
meals	meal	NNS	B-NP	O
Alert	Alert	NNP	I-NP	O
overridden	overridden	JJ	B-ADJP	O
:	:	:	O	O
Override	Override	NN	B-NP	O
added	add	VBN	B-VP	O
on	on	IN	B-PP	O
7/25/07	7/25/07	CD	B-NP	O
by	by	IN	B-PP	O
KLIEWER	KLIEWER	NNP	B-NP	O
,	,	,	O	O
LEIF	LEIF	NNP	B-NP	O
C.	C.	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
ATORVASTATIN	ATORVASTATIN	NNP	B-NP	O
CALCIUM	CALCIUM	NNP	I-NP	O
&	&	CC	I-NP	O
CYCLOSPORINE	CYCLOSPORINE	NNP	I-NP	O
Reason	Reason	NNP	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
followed	follow	VBN	B-NP	O
DILTIAZEM	DILTIAZEM	NN	I-NP	O
EXTENDED	EXTENDED	VBD	B-VP	O
RELEASE	RELEASE	NN	B-NP	B-protein
-LRB-	-LRB-	HYPH	B-NP	O
24	24	CD	I-NP	O
HR	HR	NN	I-NP	O
CAP	CAP	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
360	360	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
DAILY	DAILY	NNP	I-NP	O
Food/Drug	Food/Drug	NNP	I-NP	O
Interaction	Interaction	NNP	I-NP	O
Instruction	Instruction	NNP	I-NP	O
Avoid	Avoid	NNP	I-NP	O
grapefruit	grapefruit	NN	I-NP	O
unless	unless	IN	B-SBAR	O
MD	MD	NN	B-NP	B-DNA
instructs	instruct	NNS	I-NP	I-DNA
otherwise	otherwise	RB	B-ADVP	O
.	.	.	O	O

Override	Override	NNP	B-NP	O
Notice	Notice	NNP	I-NP	O
:	:	:	O	O
Override	Override	NNP	B-NP	O
added	add	VBD	B-VP	O
on	on	IN	B-PP	O
7/25/07	7/25/07	CD	B-NP	O
by	by	IN	B-PP	O
LISTON	LISTON	NNP	B-NP	O
,	,	,	O	O
TITUS	TITUS	NNP	B-NP	O
T	T	NNP	I-NP	O
J.	J.	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
on	on	IN	B-PP	O
order	order	NN	B-NP	O
for	for	IN	B-PP	O
SIROLIMUS	SIROLIMUS	NN	B-NP	O
PO	PO	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
ref	ref	NN	I-NP	O
#	#	#	B-NP	O
949323214	949323214	CD	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
DILTIAZEM	DILTIAZEM	NN	B-NP	O
HCL	HCL	NN	I-NP	O
&	&	CC	I-NP	O
SIROLIMUS	SIROLIMUS	NNP	I-NP	O
Reason	Reason	NNP	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
tolerates	tolerate	NNS	B-NP	O
.	.	.	O	O

will	will	MD	B-VP	O
monitor	monitor	VB	I-VP	O
ENALAPRIL	ENALAPRIL	NNP	B-NP	O
MALEATE	MALEATE	NNP	I-NP	O
10	10	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
DAILY	DAILY	NNP	I-NP	O
Override	Override	NNP	I-NP	O
Notice	Notice	NNP	I-NP	O
:	:	:	O	O
Override	Override	NNP	B-NP	O
added	add	VBD	B-VP	O
on	on	IN	B-PP	O
3/10/07	3/10/07	CD	B-NP	O
by	by	IN	B-PP	O
POPEK	POPEK	NNP	B-NP	B-protein
,	,	,	O	O
JIMMY	JIMMY	NNP	B-NP	O
C.	C.	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
on	on	IN	B-PP	O
order	order	NN	B-NP	O
for	for	IN	B-PP	O
POTASSIUM	POTASSIUM	NN	B-NP	O
CHLORIDE	CHLORIDE	NN	I-NP	O
IMMED	IMMED	NN	I-NP	O
.	.	.	O	O

REL	REL	NN	B-NP	B-protein
.	.	.	O	O

PO	PO	NN	B-NP	O
-LRB-	-LRB-	NN	I-NP	O
ref	ref	NN	I-NP	O
#	#	#	B-NP	O
868912585	868912585	CD	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
ENALAPRIL	ENALAPRIL	NNP	B-NP	O
MALEATE	MALEATE	NNP	I-NP	O
&	&	CC	I-NP	O
POTASSIUM	POTASSIUM	NNP	I-NP	O
CHLORIDE	CHLORIDE	NNP	I-NP	O
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
ENALAPRIL	ENALAPRIL	NNP	B-NP	O
MALEATE	MALEATE	NNP	I-NP	O
&	&	CC	I-NP	O
POTASSIUM	POTASSIUM	NNP	I-NP	O
CHLORIDE	CHLORIDE	NNP	I-NP	O
Reason	Reason	NNP	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
MD	MD	NN	B-NP	O
aware	aware	JJ	I-NP	O
Previous	Previous	JJ	I-NP	O
override	override	NN	I-NP	O
information	information	NN	I-NP	O
:	:	:	O	O
Override	Override	NN	B-NP	O
added	add	VBN	B-VP	O
on	on	IN	B-PP	O
3/10/07	3/10/07	CD	B-NP	O
by	by	IN	B-PP	O
BORA	BORA	NNP	B-NP	O
,	,	,	O	O
JARED	JARED	NNP	B-NP	O
N.	N.	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
on	on	IN	B-PP	O
order	order	NN	B-NP	O
for	for	IN	B-PP	O
POTASSIUM	POTASSIUM	NNP	B-NP	O
CHLORIDE	CHLORIDE	NNP	I-NP	O
SLOW	SLOW	NNP	I-NP	O
REL	REL	NNP	I-NP	O
.	.	.	O	O

TAB	TAB	NN	B-NP	B-protein
PO	PO	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
ref	ref	NN	I-NP	O
#	#	#	B-NP	O
486404126	486404126	CD	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
ENALAPRIL	ENALAPRIL	NNP	B-NP	O
MALEATE	MALEATE	NNP	I-NP	O
&	&	CC	I-NP	O
POTASSIUM	POTASSIUM	NNP	I-NP	O
CHLORIDE	CHLORIDE	NNP	I-NP	O
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
ENALAPRIL	ENALAPRIL	NNP	B-NP	O
MALEATE	MALEATE	NNP	I-NP	O
&	&	CC	I-NP	O
POTASSIUM	POTASSIUM	NNP	I-NP	O
CHLORIDE	CHLORIDE	NNP	I-NP	O
Reason	Reason	NNP	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
MD	MD	NN	B-NP	O
aware	aware	JJ	I-NP	O
LASIX	LASIX	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
FUROSEMIDE	FUROSEMIDE	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
80	80	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
DAILY	DAILY	NNP	I-NP	O
Starting	Starting	NNP	I-NP	O
Today	Today	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
5/2	5/2	CD	I-NP	O
-RRB-	-RRB-	HYPH	I-NP	O
HOLD	HOLD	NN	I-NP	B-protein
IF	IF	NN	I-NP	I-protein
:	:	:	O	O
SBP	SBP	NN	B-NP	B-protein
<	<	SYM	O	O
95	95	CD	B-NP	O
Instructions	Instruction	NNS	I-NP	O
:	:	:	O	O
For	For	IN	B-PP	O
the	the	DT	B-NP	O
next	next	JJ	I-NP	O
5	5	CD	I-NP	O
days	day	NNS	I-NP	O
,	,	,	O	O
then	then	RB	B-ADVP	O
discuss	discuss	VBP	B-VP	O
dose	dose	NN	B-NP	O
with	with	IN	B-PP	O
the	the	DT	B-NP	O
transplant	transplant	NN	I-NP	O
nurses	nurse	NNS	I-NP	O
POTASSIUM	POTASSIUM	NNP	I-NP	O
CHLORIDE	CHLORIDE	NNP	I-NP	O
SLOW	SLOW	NNP	I-NP	O
REL	REL	NNP	I-NP	O
.	.	.	O	O

TAB	TAB	NN	B-NP	B-protein
-LRB-	-LRB-	NNP	I-NP	O
KCL	KCL	NNP	I-NP	O
SLOW	SLOW	NNP	I-NP	O
RE	RE	NNP	I-NP	O
...	...	:	O	O
-RRB-	-RRB-	SYM	O	O
20	20	CD	B-NP	O
MEQ	MEQ	NN	I-NP	O
PO	PO	NN	I-NP	O
DAILY	DAILY	NN	I-NP	O
As	As	IN	B-PP	O
per	per	IN	B-PP	O
D	D	NNP	B-NP	O
Potassium	Potassium	NNP	I-NP	O
Chloride	Chloride	NNP	I-NP	O
Policy	Policy	NNP	I-NP	O
:	:	:	O	O
each	each	DT	B-NP	O
20	20	CD	I-NP	O
mEq	mEq	NN	I-NP	O
dose	dose	NN	I-NP	O
to	to	TO	B-VP	O
be	be	VB	I-VP	O
given	give	VBN	I-VP	O
with	with	IN	B-PP	O
4	4	CD	B-NP	O
oz	oz	NN	I-NP	O
of	of	IN	B-PP	O
fluid	fluid	JJ	B-NP	O
Alert	Alert	NNP	I-NP	O
overridden	overridden	JJ	I-NP	O
:	:	:	O	O
Override	Override	NN	B-NP	O
added	add	VBN	B-VP	O
on	on	IN	B-PP	O
3/10/07	3/10/07	CD	B-NP	O
by	by	IN	B-PP	O
OTHON	OTHON	NNP	B-NP	O
,	,	,	O	O
ORLANDO	ORLANDO	NNP	B-NP	O
M.	M.	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
ENALAPRIL	ENALAPRIL	NNP	B-NP	O
MALEATE	MALEATE	NNP	I-NP	O
&	&	CC	I-NP	O
POTASSIUM	POTASSIUM	NNP	I-NP	O
CHLORIDE	CHLORIDE	NNP	I-NP	O
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
ENALAPRIL	ENALAPRIL	NNP	B-NP	O
MALEATE	MALEATE	NNP	I-NP	O
&	&	CC	I-NP	O
POTASSIUM	POTASSIUM	NNP	I-NP	O
CHLORIDE	CHLORIDE	NNP	I-NP	O
Reason	Reason	NNP	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
MD	MD	NN	B-NP	O
aware	aware	JJ	I-NP	O
PREDNISONE	PREDNISONE	NN	I-NP	O
5	5	CD	I-NP	O
MG	MG	NN	I-NP	O
PO	PO	NN	I-NP	O
QAM	QAM	NN	I-NP	O
ZANTAC	ZANTAC	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
RANITIDINE	RANITIDINE	NN	I-NP	O
HCL	HCL	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
150	150	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
DAILY	DAILY	NNP	I-NP	O
Starting	Starting	NNP	I-NP	O
Today	Today	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
5/2	5/2	CD	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
SIROLIMUS	SIROLIMUS	NNP	I-NP	O
1	1	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
DAILY	DAILY	NNP	I-NP	O
Alert	Alert	NNP	I-NP	O
overridden	overridden	JJ	I-NP	O
:	:	:	O	O
Override	Override	NN	B-NP	O
added	add	VBN	B-VP	O
on	on	IN	B-PP	O
7/25/07	7/25/07	CD	B-NP	O
by	by	IN	B-PP	O
DEBIEN	DEBIEN	NNP	B-NP	O
,	,	,	O	O
JOHNATHON	JOHNATHON	NNP	B-NP	O
L.	L.	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
DILTIAZEM	DILTIAZEM	NN	B-NP	O
HCL	HCL	NN	I-NP	O
&	&	CC	I-NP	O
SIROLIMUS	SIROLIMUS	NNP	I-NP	O
Reason	Reason	NNP	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
tolerates	tolerate	NNS	B-NP	O
.	.	.	O	O

will	will	MD	B-VP	O
monitor	monitor	VB	I-VP	O
DIET	DIET	NN	B-NP	O
:	:	:	O	O
Patient	Patient	NN	B-NP	O
should	should	MD	B-VP	O
measure	measure	VB	I-VP	O
weight	weight	NN	B-NP	O
daily	daily	JJ	I-NP	O
DIET	DIET	NN	I-NP	O
:	:	:	O	O
House	House	NNP	B-NP	O
/	/	SYM	B-NP	O
Low	Low	JJ	I-NP	O
chol/low	chol/low	NN	I-NP	O
sat	sat	NN	I-NP	O
.	.	.	O	O

fat	fat	JJ	B-NP	O
ACTIVITY	ACTIVITY	NN	I-NP	O
:	:	:	O	O
Walking	Walk	VBG	B-VP	O
as	as	IN	B-SBAR	O
tolerated	tolerate	VBN	B-NP	O
FOLLOW	FOLLOW	NNP	I-NP	O
UP	UP	NNP	I-NP	O
APPOINTMENT	APPOINTMENT	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
S	S	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
:	:	:	O	O
Cardiac	Cardiac	JJ	B-NP	O
Transplant	Transplant	NN	I-NP	O
Team	Team	NN	I-NP	O
-	-	HYPH	O	O
they	they	PRP	B-NP	O
will	will	MD	B-VP	O
call	call	VB	I-VP	O
you	you	PRP	B-NP	O
to	to	TO	B-VP	O
schedule	schedule	VB	I-VP	O
appointment	appointment	NN	B-NP	O
,	,	,	O	O
Dr.	Dr.	NNP	B-NP	O
Nederostek	Nederostek	NNP	I-NP	O
10/1/07	10/1/07	CD	I-NP	O
@	@	NN	I-NP	O
10	10	CD	I-NP	O
:	:	:	O	O
50	50	CD	B-NP	O
AM	AM	NN	I-NP	O
,	,	,	O	O
ALLERGY	ALLERGY	NN	B-NP	O
:	:	:	O	O
METOPROLOL	METOPROLOL	NN	B-NP	O
TARTRATE	TARTRATE	NN	I-NP	O
ADMIT	ADMIT	NN	I-NP	O
DIAGNOSIS	DIAGNOSIS	NN	I-NP	O
:	:	:	O	O
Nausea/Vomiting/Diarrhea	Nausea/Vomiting/Diarrhea	NNP	B-NP	O
PRINCIPAL	PRINCIPAL	NNP	I-NP	O
DISCHARGE	DISCHARGE	NNP	I-NP	O
DIAGNOSIS	DIAGNOSIS	NNP	I-NP	O
;	;	:	O	O
Responsible	Responsible	JJ	B-ADJP	O
After	After	IN	B-PP	O
Study	Study	NNP	B-NP	O
for	for	IN	B-PP	O
Causing	Causing	NNP	B-NP	O
Admission	Admission	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
Cardiac	Cardiac	NNP	I-NP	O
Transplant	Transplant	NNP	I-NP	O
vasculopathy	vasculopathy	NN	I-NP	O
OTHER	OTHER	NNP	I-NP	O
DIAGNOSIS	DIAGNOSIS	NNP	I-NP	O
;	;	:	O	O
Conditions	Condition	NNS	B-NP	O
,	,	,	O	O
Infections	Infection	NNS	B-NP	O
,	,	,	O	O
Complications	Complication	NNS	B-NP	O
,	,	,	O	O
affecting	affect	VBG	B-VP	O
Treatment/Stay	Treatment/Stay	NNP	B-NP	O
HTN	HTN	NN	I-NP	O
,	,	,	O	O
High	High	JJ	B-NP	O
cholesterol	cholesterol	NN	I-NP	O
,	,	,	O	O
S/P	S/P	NN	B-NP	O
MI	MI	NN	I-NP	O
x	x	SYM	B-NP	O
4	4	CD	I-NP	O
S/P	S/P	NN	I-NP	O
CABG	CABG	NN	I-NP	O
26	26	CD	I-NP	O
of	of	IN	B-PP	O
August	August	NNP	B-NP	O
pulmonary	pulmonary	JJ	I-NP	O
nodule	nodule	NN	I-NP	O
-LRB-	-LRB-	HYPH	B-NP	O
pulmonary	pulmonary	JJ	I-NP	O
nodule	nodule	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
OPERATIONS	OPERATIONS	NNS	I-NP	O
AND	AND	CC	I-NP	O
PROCEDURES	PROCEDURES	NNS	I-NP	O
:	:	:	O	O
None	None	NN	B-NP	O
OTHER	OTHER	NN	I-NP	O
TREATMENTS/PROCEDURES	TREATMENTS/PROCEDURES	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
NOT	NOT	NNP	I-NP	O
IN	IN	NNP	I-NP	O
O.R.	O.R.	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
Dobutamine	Dobutamine	NNP	I-NP	O
Stress	Stress	NNP	I-NP	O
Echo	Echo	NNP	I-NP	O
6/18/07	6/18/07	CD	I-NP	O
Right	Right	NNP	I-NP	O
heart	heart	NN	I-NP	O
catheterization	catheterization	NN	I-NP	O
and	and	CC	O	O
biopsy	biopsy	NN	B-NP	O
4/8/07	4/8/07	CD	I-NP	O
BRIEF	BRIEF	NN	I-NP	O
RESUME	RESUME	NN	I-NP	O
OF	OF	IN	B-PP	O
HOSPITAL	HOSPITAL	JJ	B-NP	O
COURSE	COURSE	NN	I-NP	O
:	:	:	O	O
CC	CC	NN	B-NP	O
:	:	:	O	O
N/V/D	N/V/D	NN	B-NP	O
--	--	:	O	O
--	--	:	O	O
-	-	HYPH	B-NP	O
HPI	HPI	NN	I-NP	B-protein
:	:	:	O	O
62M	62M	NN	B-NP	O
h/o	h/o	NN	I-NP	O
ischemic	ischemic	JJ	I-NP	O
cardiomyopathy	cardiomyopathy	NN	I-NP	O
s/p	s/p	NN	I-NP	O
cardiac	cardiac	JJ	I-NP	O
transplant	transplant	NN	I-NP	O
in	in	IN	B-PP	O
October	October	NNP	B-NP	O
2000	2000	CD	I-NP	O
c/b	c/b	NN	I-NP	O
allograft	allograft	NN	I-NP	O
CAD	CAD	NN	I-NP	O
,	,	,	O	O
DM	DM	NN	B-NP	O
,	,	,	O	O
HTN	HTN	NN	B-NP	B-protein
.	.	.	O	O

He	He	PRP	B-NP	O
has	have	VBZ	B-VP	O
been	be	VBN	I-VP	O
doing	do	VBG	I-VP	O
well	well	RB	B-ADVP	O
in	in	IN	B-PP	O
his	his	PRP$	B-NP	O
USOH	USOH	NN	I-NP	B-protein
until	until	IN	B-SBAR	O
he	he	PRP	B-NP	O
developed	develop	VBD	B-VP	O
nausea	nausea	NN	B-NP	O
and	and	CC	O	O
vomiting	vomit	VBG	B-VP	O
2	2	CD	B-NP	O
days	day	NNS	I-NP	O
prior	prior	RB	B-ADVP	O
to	to	TO	B-PP	O
admission	admission	NN	B-NP	O
.	.	.	O	O

No	No	DT	B-NP	O
unusual	unusual	JJ	I-NP	O
foods	food	NNS	I-NP	O
,	,	,	O	O
no	no	DT	B-NP	O
sick	sick	JJ	I-NP	O
contacts	contact	NNS	I-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
had	have	VBD	B-VP	O
some	some	DT	B-NP	O
``	``	``	I-NP	O
discomfort	discomfort	NN	I-NP	O
''	''	''	O	O
in	in	IN	B-PP	O
his	his	PRP$	B-NP	O
stomach	stomach	NN	I-NP	O
on	on	IN	B-PP	O
Monday	Monday	NNP	B-NP	O
that	that	WDT	B-NP	O
seemed	seem	VBD	B-VP	O
to	to	TO	I-VP	O
get	get	VB	I-VP	O
better	good	JJR	B-NP	O
briefly	briefly	NN	I-NP	O
before	before	IN	B-SBAR	O
he	he	PRP	B-NP	O
developed	develop	VBD	B-VP	O
diarrhea	diarrhea	NN	B-NP	O
and	and	CC	I-NP	O
vomiting	vomiting	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
following	follow	VBG	I-NP	O
day	day	NN	I-NP	O
he	he	PRP	B-NP	O
felt	feel	VBD	B-VP	O
weak	weak	JJ	B-ADJP	O
,	,	,	O	O
did	do	VBD	B-VP	O
n't	n't	RB	I-VP	O
get	get	VB	I-VP	O
out	out	IN	B-PP	O
of	of	IN	B-PP	O
bed	bed	NN	B-NP	O
and	and	CC	O	O
had	have	VBD	B-VP	O
watery	watery	NN	B-NP	O
non-bloody	non-bloody	JJ	I-NP	O
diarrhea	diarrhea	NN	I-NP	O
with	with	IN	B-PP	O
~	~	NN	B-NP	B-protein
10	10	CD	B-NP	I-protein
BMs	BM	NNS	I-NP	I-protein
throughout	throughout	IN	B-PP	O
the	the	DT	B-NP	O
day	day	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
NBNB	NBNB	NN	B-NP	O
emesis	emesis	NN	I-NP	O
.	.	.	O	O

On	On	IN	B-PP	O
AM	AM	NN	B-NP	O
of	of	IN	B-PP	O
admission	admission	NN	B-NP	O
he	he	PRP	B-NP	O
still	still	RB	B-ADVP	O
felt	feel	VBD	B-VP	O
poorly	poorly	RB	B-ADVP	O
and	and	CC	O	O
came	come	VBD	B-VP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
ED	ED	NNP	I-NP	O
.	.	.	O	O

Poor	Poor	NN	B-NP	O
po	po	NN	I-NP	O
intake	intake	NN	I-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
has	have	VBZ	B-VP	O
had	have	VBN	I-VP	O
no	no	DT	B-NP	O
orthopnea	orthopnea	NN	I-NP	O
,	,	,	O	O
PND	PND	NN	B-NP	B-protein
,	,	,	O	O
lower	low	JJR	B-NP	O
extremity	extremity	NN	I-NP	O
edema	edema	NN	I-NP	O
and	and	CC	O	O
denies	deny	VBZ	B-VP	O
palpitations	palpitation	NNS	B-NP	O
,	,	,	O	O
lightheadedness	lightheadedness	NN	B-NP	O
,	,	,	O	O
or	or	CC	O	O
syncope	syncope	NN	B-NP	O
.	.	.	O	O

His	His	PRP$	B-NP	O
review	review	NN	I-NP	O
of	of	IN	B-PP	O
systems	system	NNS	B-NP	O
is	be	VBZ	B-VP	O
negative	negative	JJ	B-ADJP	O
in	in	IN	B-PP	O
detail	detail	NN	B-NP	O
with	with	IN	B-PP	O
no	no	DT	B-NP	O
recent	recent	JJ	I-NP	O
history	history	NN	I-NP	O
of	of	IN	B-PP	O
fever	fever	NN	B-NP	O
,	,	,	O	O
chills	chill	NNS	B-NP	O
,	,	,	O	O
nausea	nausea	NN	B-NP	O
,	,	,	O	O
or	or	CC	O	O
neurologic	neurologic	JJ	B-NP	O
symptoms	symptom	NNS	I-NP	O
.	.	.	O	O

In	In	IN	B-PP	O
the	the	DT	B-NP	O
ED	ED	NN	I-NP	O
he	he	PRP	B-NP	O
received	receive	VBD	B-VP	O
a	a	DT	B-NP	O
bolus	bolus	NN	I-NP	O
on	on	IN	B-PP	O
NS	NS	NN	B-NP	O
500cc	500cc	CD	I-NP	O
and	and	CC	O	O
has	have	VBZ	B-VP	O
felt	feel	VBN	I-VP	O
better	good	JJR	B-ADJP	O
without	without	IN	B-PP	O
any	any	DT	B-NP	O
N/V/D	N/V/D	NN	I-NP	B-protein
and	and	CC	I-NP	O
feels	feel	NNS	I-NP	O
like	like	IN	B-PP	O
``	``	``	O	O
he	he	PRP	B-NP	O
could	could	MD	B-VP	O
lift	lift	VB	I-VP	O
a	a	DT	B-NP	O
cow	cow	NN	I-NP	O
''	''	''	O	O
.	.	.	O	O

He	He	PRP	B-NP	O
had	have	VBD	B-VP	O
cardiac	cardiac	JJ	B-NP	B-protein
enzymes	enzyme	NNS	I-NP	I-protein
sent	send	VBN	B-VP	O
which	which	WDT	B-NP	O
revealed	reveal	VBD	B-VP	O
a	a	DT	B-NP	O
TnI	TnI	NN	I-NP	B-protein
of	of	IN	B-PP	O
0.06	0.06	CD	B-NP	O
and	and	CC	I-NP	O
2nd	2nd	CD	I-NP	O
set	set	NN	I-NP	O
0.09	0.09	CD	B-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
is	be	VBZ	B-VP	O
admitted	admit	VBN	I-VP	O
to	to	TO	I-VP	O
trend	trend	VB	I-VP	O
his	his	PRP$	B-NP	O
cardiac	cardiac	JJ	I-NP	B-protein
enzymes	enzyme	NNS	I-NP	I-protein
and	and	CC	B-PP	O
for	for	IN	B-PP	O
Dobutamine	Dobutamine	NN	B-NP	O
stress	stress	NN	I-NP	O
test	test	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
morning	morning	NN	I-NP	O
.	.	.	O	O

--	--	:	O	O
--	--	:	O	O
-	-	:	O	O
PMH	PMH	NN	B-NP	O
:	:	:	O	O
HTN	HTN	NN	B-NP	B-protein
,	,	,	O	O
hyperlipidemia	hyperlipidemia	NN	B-NP	O
,	,	,	O	O
pretransplant	pretransplant	NN	B-NP	O
CAD	CAD	NN	I-NP	O
,	,	,	O	O
allograft	allograft	NN	B-NP	O
coronary	coronary	JJ	I-NP	O
disease	disease	NN	I-NP	O
--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
MEDS	MEDS	NN	B-NP	O
:	:	:	O	O
Plavix	Plavix	NN	B-NP	O
75mg	75mg	CD	I-NP	O
daily	daily	JJ	I-NP	O
Diltiazem	Diltiazem	NNP	I-NP	O
ER	ER	NN	I-NP	O
360mg	360mg	CD	I-NP	O
daily	daily	JJ	I-NP	O
Enalapril	Enalapril	NNP	I-NP	O
10mg	10mg	CD	I-NP	O
daily	daily	JJ	I-NP	O
Lipitor	Lipitor	NNP	I-NP	O
80mg	80mg	CD	I-NP	O
daily	daily	JJ	I-NP	O
Lasix	Lasix	NNP	I-NP	O
40mg	40mg	CD	I-NP	O
daily	daily	JJ	I-NP	O
K-Dur	K-Dur	NNP	I-NP	O
20meq	20meq	NN	I-NP	O
daily	daily	JJ	I-NP	O
Prednisone	Prednisone	NN	I-NP	O
5mg	5mg	NN	I-NP	O
daily	daily	JJ	I-NP	O
Sirolimus	Sirolimus	NNP	I-NP	O
1mg	1mg	NN	I-NP	O
daily	daily	JJ	I-NP	O
Cyclosporine	Cyclosporine	NN	I-NP	O
25mg	25mg	NN	I-NP	O
BID	BID	NNP	I-NP	O
Zantac	Zantac	NNP	I-NP	O
150mg	150mg	NN	I-NP	O
daily	daily	RB	B-ADVP	O
--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
ALL	ALL	NN	B-NP	O
:	:	:	O	O
Metoprolol	Metoprolol	NN	B-NP	O
--	--	:	O	O
>	>	SYM	B-NP	O
hypotension/arrest	hypotension/arrest	NN	I-NP	O
--	--	:	O	O
--	--	:	O	O
-	-	HYPH	B-NP	O
STATUS	STATUS	NNS	I-NP	O
:	:	:	O	O
VS	VS	NN	B-NP	O
100.2	100.2	CD	B-NP	O
110130/90	110130/90	CD	I-NP	O
20	20	CD	I-NP	O
97	97	CD	I-NP	O
%	%	NN	I-NP	O
RA	RA	NN	I-NP	O
nad	nad	NN	I-NP	O
,	,	,	O	O
perrl	perrl	NN	B-NP	O
,	,	,	O	O
mmm	mmm	NN	B-NP	O
,	,	,	O	O
jvp	jvp	NN	B-NP	O
flat	flat	JJ	B-ADJP	O
,	,	,	O	O
rrr	rrr	VBP	B-VP	O
no	no	DT	B-NP	O
m/r/g	m/r/g	NN	I-NP	O
,	,	,	O	O
ctab	ctab	NN	B-NP	O
,	,	,	O	O
abd	abd	NN	B-NP	O
soft	soft	JJ	I-NP	O
nt	nt	NN	I-NP	O
,	,	,	O	O
no	no	DT	B-NP	O
c/c/e	c/c/e	NN	I-NP	O
.	.	.	O	O

a	a	DT	B-NP	O
+	+	JJ	I-NP	O
ox3	ox3	NN	I-NP	O
,	,	,	O	O
non-focal	non-focal	JJ	B-NP	O
neuro	neuro	NN	I-NP	O
.	.	.	O	O

--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
-	-	HYPH	B-NP	O
TESTS	TESTS	NNS	I-NP	O
:	:	:	O	O
UA	UA	NN	B-NP	O
:	:	:	O	O
1.024	1.024	CD	B-NP	O
,	,	,	I-NP	O
1	1	CD	I-NP	O
+	+	SYM	I-NP	O
ket	ket	NN	I-NP	O
-	-	HYPH	I-NP	O
LE	LE	NN	I-NP	B-cell_type
/	/	SYM	B-NP	I-cell_type
-	-	HYPH	B-NP	O
NIT	NIT	NN	I-NP	B-protein
CXR	CXR	NN	I-NP	I-protein
:	:	:	O	O
bandlike	bandlike	VB	B-VP	O
opacity	opacity	NN	B-NP	O
w	w	NN	I-NP	O
pleural	pleural	JJ	I-NP	O
thickening	thickening	NN	I-NP	O
on	on	IN	B-PP	O
R	R	NN	B-NP	B-protein
base	base	NN	I-NP	I-protein
.	.	.	O	O

else	else	RB	B-NP	O
-	-	HYPH	I-NP	O
ve	ve	NN	I-NP	O
.	.	.	O	O

Echo	Echo	NNP	B-NP	O
5/7	5/7	CD	I-NP	O
55	55	CD	I-NP	O
%	%	NN	I-NP	O
EF	EF	NN	I-NP	O
no	no	DT	B-NP	O
wma	wma	NN	I-NP	O
Prior	Prior	NNP	I-NP	O
Stress	Stress	NNP	I-NP	O
Echo	Echo	NNP	I-NP	O
:	:	:	O	O
-	-	HYPH	B-NP	O
ve	ve	NN	I-NP	O
Dobutamine	Dobutamine	NN	I-NP	O
stress	stress	NN	I-NP	O
echo	echo	NN	I-NP	O
3/5	3/5	CD	I-NP	O
unchanged	unchanged	JJ	B-ADJP	O
from	from	IN	B-PP	O
prior	prior	JJ	B-ADJP	O
,	,	,	O	O
no	no	DT	B-NP	O
WMA	WMA	NN	I-NP	O
--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
-	-	HYPH	B-NP	O
HOSPITAL	HOSPITAL	NN	I-NP	O
COURSE	COURSE	NN	I-NP	O
BY	BY	NN	I-NP	O
PROBLEM	PROBLEM	NN	I-NP	O
:	:	:	O	O
#	#	#	B-NP	O
N	N	NN	I-NP	O
/	/	SYM	B-NP	O
V/DIARRHEA	V/DIARRHEA	NN	I-NP	O
:	:	:	O	O
likely	likely	JJ	B-NP	O
viral	viral	JJ	I-NP	O
gastroenteritis	gastroenteritis	NN	I-NP	O
given	give	VBN	B-VP	O
quick	quick	JJ	B-NP	O
resolution	resolution	NN	I-NP	O
,	,	,	O	O
no	no	DT	B-NP	O
further	further	JJ	I-NP	O
n/v/d	n/v/d	NN	I-NP	O
,	,	,	O	O
made	make	VBD	B-VP	O
no	no	DT	B-NP	O
stool	stool	NN	I-NP	O
to	to	TO	B-VP	O
send	send	VB	I-VP	O
for	for	IN	B-PP	O
stool	stool	NN	B-NP	O
studies	study	NNS	I-NP	O
.	.	.	O	O

#	#	#	B-NP	O
CV	CV	NN	I-NP	O
-	-	HYPH	B-NP	O
i	i	NN	I-NP	O
:	:	:	O	O
severe	severe	JJ	B-NP	O
allograft	allograft	NN	I-NP	O
vasculopathy	vasculopathy	NN	I-NP	O
,	,	,	O	O
suspect	suspect	NN	B-NP	O
demand	demand	NN	I-NP	O
ischemia	ischemia	NN	I-NP	O
given	give	VBN	B-VP	O
tachycardia	tachycardia	NN	B-NP	O
and	and	CC	I-NP	O
HTN	HTN	NN	I-NP	B-protein
on	on	IN	B-PP	O
admission	admission	NN	B-NP	O
vs	vs	IN	B-PP	O
rejection	rejection	NN	B-NP	O
.	.	.	O	O

Continued	Continue	VBN	B-NP	O
plavix	plavix	NN	I-NP	O
,	,	,	O	O
ccb	ccb	NN	B-NP	B-protein
,	,	,	O	O
acei	acei	NN	B-NP	O
,	,	,	O	O
statin	statin	NN	B-NP	O
.	.	.	O	O

not	not	RB	O	O
on	on	IN	B-PP	O
ASA	ASA	NN	B-NP	O
.	.	.	O	O

Trended	Trend	VBN	B-NP	B-protein
enzymes	enzyme	NNS	I-NP	I-protein
;	;	:	O	O
CK	CK	NN	B-NP	O
and	and	CC	I-NP	O
MB	MB	NN	I-NP	B-protein
remained	remain	VBD	B-VP	O
flat	flat	JJ	B-ADJP	O
,	,	,	O	O
TnI	TnI	NN	B-NP	B-protein
peaked	peak	VBD	B-VP	O
at	at	IN	B-PP	O
0.13	0.13	CD	B-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
had	have	VBD	B-VP	O
a	a	DT	B-NP	O
repeat	repeat	NN	I-NP	O
dobutamine	dobutamine	NN	I-NP	O
stress	stress	NN	I-NP	O
echo	echo	NN	I-NP	O
without	without	IN	B-PP	O
evidence	evidence	NN	B-NP	O
of	of	IN	B-PP	O
ischemia	ischemia	NN	B-NP	O
,	,	,	O	O
no	no	DT	B-NP	O
WMA	WMA	NN	I-NP	O
.	.	.	O	O

#	#	#	B-NP	O
CV	CV	NN	I-NP	O
-	-	HYPH	O	O
p	p	NN	B-NP	O
:	:	:	O	O
volume	volume	NN	B-NP	O
down	down	RP	B-PRT	O
2/2	2/2	CD	B-NP	O
vomiting	vomiting	NN	I-NP	O
and	and	CC	I-NP	O
diarrhea	diarrhea	NN	I-NP	O
.	.	.	O	O

Held	Held	NNP	B-NP	O
lasix	lasix	CD	I-NP	O
o/n	o/n	NN	I-NP	O
.	.	.	O	O

Gentle	Gentle	NN	B-NP	O
hydration	hydration	NN	I-NP	O
w	w	NN	I-NP	O
IVF	IVF	NN	I-NP	O
overnight	overnight	RB	B-ADVP	O
.	.	.	O	O

cont	cont	JJ	B-NP	O
home	home	NN	I-NP	O
antihypertensives	antihypertensive	NNS	I-NP	O
.	.	.	O	O

RHC	RHC	NN	B-NP	B-protein
revealed	reveal	VBD	B-VP	O
elevated	elevated	JJ	B-NP	O
left	left	JJ	I-NP	O
heart	heart	NN	I-NP	O
filling	filling	NN	I-NP	O
pressures	pressure	NNS	I-NP	O
-LRB-	-LRB-	SYM	B-VP	O
PCWP	PCWP	NN	B-NP	B-protein
24	24	CD	I-NP	I-protein
-RRB-	-RRB-	NN	I-NP	I-protein
therefore	therefore	RB	B-ADVP	O
will	will	MD	B-VP	O
double	double	VB	I-VP	O
his	his	PRP$	B-NP	O
lasix	lasix	NN	I-NP	O
dose	dose	NN	I-NP	O
on	on	IN	B-PP	O
discharge	discharge	NN	B-NP	O
to	to	TO	B-PP	O
80mg	80mg	CD	B-NP	O
daily	daily	RB	B-ADVP	O
and	and	CC	O	O
he	he	PRP	B-NP	O
will	will	MD	B-VP	O
discuss	discuss	VB	I-VP	O
with	with	IN	B-PP	O
transplant	transplant	NN	B-NP	O
nurses	nurse	NNS	I-NP	O
next	next	IN	B-NP	O
week	week	NN	I-NP	O
resuming	resume	VBG	B-VP	O
the	the	DT	B-NP	O
prior	prior	JJ	I-NP	O
dose	dose	NN	I-NP	O
.	.	.	O	O

#	#	#	B-NP	O
CV	CV	NN	I-NP	O
-	-	HYPH	O	O
r/r	r/r	NN	B-NP	O
:	:	:	O	O
sinus	sinus	NN	B-NP	O
tachy	tachy	NN	I-NP	O
likely	likely	RB	B-NP	O
2/2	2/2	CD	I-NP	O
hypovolemia	hypovolemia	NN	I-NP	O
,	,	,	O	O
gentle	gentle	JJ	B-NP	O
IVFs	IVF	NNS	I-NP	O
,	,	,	O	O
on	on	IN	B-PP	O
ccb	ccb	NN	B-NP	O
#	#	#	I-NP	O
CARDIAC	CARDIAC	NN	I-NP	O
TRANSPLANT	TRANSPLANT	NN	I-NP	O
:	:	:	O	O
continuted	continute	VBN	B-NP	O
home	home	NN	I-NP	O
immunosuppressive	immunosuppressive	JJ	I-NP	O
meds	med	NNS	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
prednisone	prednisone	NN	I-NP	O
,	,	,	O	O
sirolimus	sirolimus	NN	B-NP	O
,	,	,	O	O
cyclosporin	cyclosporin	NN	B-NP	O
-RRB-	-RRB-	NN	I-NP	O
.	.	.	O	O

Sirolimus	Sirolimus	NN	B-NP	O
level	level	NN	I-NP	O
elevated	elevate	VBD	B-VP	O
at	at	IN	B-PP	O
38	38	CD	B-NP	O
-LRB-	-LRB-	NN	I-NP	O
?	?	.	O	O

true	true	JJ	B-NP	O
trough	trough	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
had	have	VBD	B-VP	O
a	a	DT	B-NP	O
RHC	RHC	NN	I-NP	B-protein
and	and	CC	I-NP	O
biopsy	biopsy	NN	I-NP	O
on	on	IN	B-PP	O
4/5	4/5	CD	B-NP	O
,	,	,	O	O
final	final	JJ	B-NP	O
path	path	NN	I-NP	O
pending	pende	VBG	B-VP	O
at	at	IN	B-PP	O
discharge	discharge	NN	B-NP	O
#	#	#	B-NP	O
ENDO	ENDO	NNP	I-NP	O
:	:	:	O	O
was	be	VBD	B-VP	O
on	on	IN	B-PP	O
glipizide	glipizide	NN	B-NP	B-protein
recently	recently	RB	B-ADVP	I-protein
d/c	d/c	VBD	B-VP	I-protein
2/2	2/2	CD	B-NP	I-protein
low	low	JJ	I-NP	I-protein
blood	blood	NN	I-NP	I-protein
sugars	sugar	NNS	I-NP	I-protein
.	.	.	O	O

HgA1c	HgA1c	NN	B-NP	B-protein
elevated	elevate	VBD	B-VP	O
at	at	IN	B-PP	O
9.2	9.2	CD	B-NP	O
,	,	,	O	O
but	but	CC	O	O
blood	blood	NN	B-NP	O
glucose	glucose	NN	I-NP	O
<	<	SYM	B-NP	O
130	130	CD	B-NP	O
throughtout	throughtout	IN	B-PP	O
admission	admission	NN	B-NP	O
.	.	.	O	O

#	#	#	B-NP	O
PPx	PPx	NN	I-NP	B-protein
:	:	:	O	O
lovenox	lovenox	NN	B-NP	O
,	,	,	O	O
h2	h2	NN	B-NP	O
blocker	blocker	NN	I-NP	O
#	#	#	B-NP	O
FULL	FULL	NNP	I-NP	O
CODE	CODE	NNP	I-NP	O
ADDITIONAL	ADDITIONAL	NNP	I-NP	O
COMMENTS	COMMENTS	NNS	I-NP	O
:	:	:	O	O
You	You	PRP	B-NP	O
were	be	VBD	B-VP	O
admitted	admit	VBN	I-VP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
hospital	hospital	NN	I-NP	O
because	because	IN	B-PP	O
of	of	IN	I-PP	O
your	your	PRP$	B-NP	O
nausea	nausea	NN	I-NP	O
,	,	,	I-NP	O
vomiting	vomiting	NN	I-NP	O
and	and	CC	I-NP	O
diarrhea	diarrhea	NN	I-NP	O
and	and	CC	O	O
were	be	VBD	B-VP	O
found	find	VBN	I-VP	O
to	to	TO	I-VP	O
have	have	VB	I-VP	O
abnormalities	abnormality	NNS	B-NP	O
some	some	DT	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
enzymes	enzyme	NNS	I-NP	B-protein
released	release	VBN	B-VP	O
from	from	IN	B-PP	O
your	your	PRP$	B-NP	O
heart	heart	NN	I-NP	O
;	;	:	O	O
you	you	PRP	B-NP	O
had	have	VBD	B-VP	O
a	a	DT	B-NP	O
repeat	repeat	NN	I-NP	O
Stress	Stress	NNP	I-NP	O
Echo	Echo	NNP	I-NP	O
which	which	WDT	B-NP	O
showed	show	VBD	B-VP	O
no	no	DT	B-NP	O
change	change	NN	I-NP	O
from	from	IN	B-PP	O
the	the	DT	B-NP	O
one	one	CD	I-NP	O
done	do	VBN	B-VP	O
in	in	IN	B-PP	O
October	October	NNP	B-NP	O
.	.	.	O	O

You	You	PRP	B-NP	B-protein
will	will	MD	B-VP	O
get	get	VB	I-VP	O
the	the	DT	B-NP	O
results	result	NNS	I-NP	O
of	of	IN	B-PP	O
your	your	PRP$	B-NP	O
biopsy	biopsy	NN	I-NP	O
next	next	IN	B-NP	O
week	week	NN	I-NP	O
.	.	.	O	O

Please	Please	VB	B-VP	O
call	call	VB	I-VP	O
your	your	PRP$	B-NP	O
doctor	doctor	NN	I-NP	O
or	or	CC	O	O
return	return	VB	B-VP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
Emergency	Emergency	NNP	I-NP	O
Department	Department	NNP	I-NP	O
if	if	IN	B-SBAR	O
you	you	PRP	B-NP	O
have	have	VBP	B-VP	O
any	any	DT	B-NP	O
discomfort	discomfort	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
chest	chest	NN	I-NP	O
,	,	,	O	O
more	more	JJR	B-NP	O
nausea	nausea	NN	I-NP	O
,	,	,	O	O
vomiting	vomiting	NN	B-NP	O
or	or	CC	I-NP	O
diarrhea	diarrhea	NN	I-NP	O
,	,	,	O	O
lightheadedness/dizziness	lightheadedness/dizziness	NN	B-NP	O
,	,	,	O	O
fatigue	fatigue	NN	B-NP	O
,	,	,	O	O
difficulty	difficulty	NN	B-NP	O
breathing	breathing	NN	I-NP	O
,	,	,	O	O
fevers/chills	fevers/chill	NNS	B-NP	O
or	or	CC	O	O
any	any	DT	B-NP	O
other	other	JJ	I-NP	O
symptoms	symptom	NNS	I-NP	O
concerning	concern	VBG	B-VP	O
to	to	TO	B-PP	O
you	you	PRP	B-NP	O
.	.	.	O	O

You	You	PRP	B-NP	B-protein
should	should	MD	B-VP	O
continue	continue	VB	I-VP	O
taking	take	VBG	I-VP	O
all	all	DT	B-NP	O
of	of	IN	B-PP	O
your	your	PRP$	B-NP	O
medications	medication	NNS	I-NP	O
as	as	IN	B-SBAR	O
before	before	RB	B-ADVP	O
except	except	IN	B-PP	O
for	for	IN	B-PP	O
Lasix	Lasix	NNP	B-NP	O
,	,	,	O	O
take	take	VBP	B-VP	O
a	a	DT	B-NP	O
double	double	JJ	I-NP	O
dose	dose	NN	I-NP	O
until	until	IN	B-SBAR	O
you	you	PRP	B-NP	O
speak	speak	VBP	B-VP	O
with	with	IN	B-PP	O
the	the	DT	B-NP	O
transplant	transplant	NN	I-NP	O
nurses	nurse	NNS	I-NP	O
next	next	IN	B-NP	O
week	week	NN	I-NP	O
.	.	.	O	O

DISCHARGE	DISCHARGE	NN	B-NP	O
CONDITION	CONDITION	NN	I-NP	O
:	:	:	O	O
Stable	Stable	JJ	B-NP	O
TO	TO	NN	I-NP	O
DO/PLAN	DO/PLAN	NN	I-NP	O
:	:	:	O	O
Please	Please	NN	B-NP	O
monitor	monitor	NN	I-NP	O
Cyclosporine	Cyclosporine	NN	I-NP	O
and	and	CC	I-NP	O
Sirolimus	Sirolimus	NN	I-NP	O
levels	level	NNS	I-NP	O
No	No	DT	B-NP	O
dictated	dictated	JJ	I-NP	O
summary	summary	NN	I-NP	O
ENTERED	ENTERED	NNP	I-NP	O
BY	BY	NNP	I-NP	O
:	:	:	O	O
MERCURIO	MERCURIO	NNP	B-NP	O
,	,	,	O	O
LAMONT	LAMONT	NNP	B-NP	O
N.	N.	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
-LRB-	-LRB-	NNP	I-NP	O
XG72	XG72	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
3/10/07	3/10/07	CD	I-NP	O
@	@	NN	I-NP	O
02	02	CD	I-NP	O
:	:	:	O	O
59	59	CD	B-NP	O
PM	PM	NN	I-NP	O
******	******	SYM	B-NP	O
END	END	NN	I-NP	O
OF	OF	IN	B-PP	O
DISCHARGE	DISCHARGE	NN	B-NP	O
ORDERS	ORDERS	NNS	I-NP	O
******	******	SYM	B-NP	O

